5.2.4 Age, genetics, and comorbidities Individual susceptibility to the neurotoxic effects of ketamine varies according to age, genetic factors, and comorbidities
Animal studies show BPC-157 increases VEGF mRNA expression by 2.5 to 4 baseline in injured tissue within 48 hours
Setting/location The study was conducted at Bastyr University Research Institute, Kenmore, WA and the Bastyr Center for Natural Health, Seattle, WA
These findings suggest that AST protects dopaminergic neurons through suppression of ER stress and stabilization of the miR-7/SNCA regulatory loop, presenting a promising target for PD therapy (Shen et al., 2021)
This may be due to various study limitations, such as variability of the study populations, non-homogeneous groups, unspecified sample size, different analytical methods employed, and transportation of selenium to the fetus: thus, conclusions about causal relationships cannot be drawn [27]